Literature DB >> 2187098

Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 A resolution.

A G Leslie1.   

Abstract

High level bacterial resistance to chloramphenicol is generally due to O-acetylation of the antibiotic in a reaction catalysed by chloramphenicol acetyltransferase (CAT, EC 2.3.1.28) in which acetyl-coenzyme A is the acyl donor. The crystal structure of the type III enzyme from Escherichia coli with chloramphenicol bound has been determined and refined at 1.75 A resolution, using a restrained parameter reciprocal space least squares procedure. The refined model, which includes chloramphenicol, 204 solvent molecules and two cobalt ions has a crystallographic R-factor of 18.3% for 27,300 reflections between 6 and 1.75 A resolution. The root-mean-square deviation in bond lengths from ideal values is 0.02 A. The cobalt ions play a crucial role in stabilizing the packing of the molecule in the crystal lattice. CAT is a trimer of identical subunits (monomer Mr 25,000) and the trimeric structure is stabilized by a number of hydrogen bonds, some of which result in the extension of a beta-sheet across the subunit interface. Chloramphenicol binds in a deep pocket located at the boundary between adjacent subunits of the trimer, such that the majority of residues forming the binding pocket belong to one subunit while the catalytically essential histidine belongs to the adjacent subunit. His195 is appropriately positioned to act as a general base catalyst in the reaction, and the required tautomeric stabilization is provided by an unusual interaction with a main-chain carbonyl oxygen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187098     DOI: 10.1016/S0022-2836(05)80129-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  32 in total

1.  Statistical relationships among docking scores for different protein binding sites.

Authors:  R T Koehler; H O Villar
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex.

Authors:  A Kaykas; K Worringer; B Sugden
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

3.  Flexsim-R: a virtual affinity fingerprint descriptor to calculate similarities of functional groups.

Authors:  Alexander Weber; Andreas Teckentrup; Hans Briem
Journal:  J Comput Aided Mol Des       Date:  2002-12       Impact factor: 3.686

4.  The chloramphenicol acetyltransferase gene of Tn2424: a new breed of cat.

Authors:  R Parent; P H Roy
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

5.  Comparative sequence analysis of the catB gene from Clostridium butyricum.

Authors:  A S Huggins; T L Bannam; J I Rood
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 6.  Structure and noncanonical chemistry of nonribosomal peptide biosynthetic machinery.

Authors:  Heather L Condurso; Steven D Bruner
Journal:  Nat Prod Rep       Date:  2012-06-25       Impact factor: 13.423

7.  Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins.

Authors:  P N Rather; H Munayyer; P A Mann; R S Hare; G H Miller; K J Shaw
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

8.  StoneHinge: hinge prediction by network analysis of individual protein structures.

Authors:  Kevin S Keating; Samuel C Flores; Mark B Gerstein; Leslie A Kuhn
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

Review 9.  Acyltransferases in bacteria.

Authors:  Annika Röttig; Alexander Steinbüchel
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

10.  Six new candidate members of the alpha/beta twisted open-sheet family detected by sequence similarity to flavodoxin.

Authors:  R Grandori; J Carey
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.